《新股消息》鴻承環保科技(02265.HK)超購23倍下限定價 一手中籤率50%
中國有害廢物處理公司鴻承環保科技(02265.HK)公布招股結果,每股發售價定為1.02元,為招股價1.02至1.48元的下限定價,香港公開發售部分錄得超額認購約23.26倍,每手5,000股計,一手中籤50.01%,要認購5萬股即10手才穩獲一手。該股將於明日(12日)掛牌。第一上海融資為是次上市的獨家保薦人。
由於香港公開發售部份超額認購逾15倍或以上,因此獲重新分配,公開發售股份最終佔全球發售股份總數30%。
公司料是次上市淨集資約2.16億元,擬將約86.7%用於提高產能和實力,以鞏固市場地位;約3.9%用於加強研發能力;約9.4%用作一般營運資金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.